Sinovac Biotech Ltd Net Income per Employee (SVA), current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket
 


Sinovac Biotech Ltd  (NASDAQ: SVA)
 

Sinovac Biotech Ltd Net Income per Employee

SVA's Quarterly Results, Trends, Rankings, Statistics
Sinovac Biotech Ltd recorded a cumulative net loss of $-199 million during 12 month ending in the fourth quarter 2025.
The Healthcare sector has seen employees of 109 other companies achieving higher income per employee. While Sinovac Biotech Ltd's total ranking has deteriorated compared to the previous quarter from 1572 to 3327.


What is Income per Employee Ratio?






SVA Net Income per Employee (Dec 31 2025)
IV. Quarter
0
III. Quarter
0
II. Quarter
0
I. Quarter
(Dec 31 2024)
IV. Quarter
Y / Y Net Income Change - - - - -
Net Income per Employee (TTM) $ -76,417 15,625 15,625 15,625 15,625
SVA's Total Ranking # 3327 # 1572 # # #
Seq. Net Income Change - - - - -


SVA Net Income per Employee Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 110
Healthcare Sector # 335
Overall Market # 3327

Net Income per Employee Statistics
High Average Low
$ 5,556,845 $ 504,954 $ -99,291
(Dec 31 2021)   (Dec 31 2023)







Companies with similar Income per Employee for 12 month ending Dec 31 2025, within Healthcare Sector Income per Employee Income 12 month ending Dec 31 2025Number of Employees Dec 31 2025


Date modified: 2026-09-08T15:22:17+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.